InnovaQor, Inc. Announces Launch of an Automated Implementation for its Medical Mime EHR Solution
October 12, 2021 at 02:15 pm
Share
InnovaQor, Inc. announced the launch of an automated implementation process for their Medical Mime EHR solution. InnovaQor is pleased to confirm its subsidiary Medical Mime has launched an automated implementation process to make it easier for rehabilitation and substance abuse treatment centers to transition from an existing EHR to its Medical Mime solution. Operational disruption moving from one system to a more robust and efficient platform, is a major challenge for all rehabilitation and substance abuse treatment centers and can be an insurmountable hurdle for many providers who want to transition to a new solution. Medical Mime’s automated implementation process removes this hurdle and reduces paperwork and time required during a typical implementation. Medical Mime aims to create efficiencies and reduce loss for its customers by improving the volume intake through a more streamlined and accountable process that is less reliant on staff input or completion.
InnovaQor, Inc. is engaged in providing information technology solutions and services to healthcare and laboratory customers in the United States. The Companyâs services include HTS vCIO, HTS Qira, Medical Mime, ClinLab and MEDtuning. Its HTS vCIO services include consulting and strategic alignment, software and hardware implementation and management, vendor management, risk analysis and risk management and cybersecurity and proactive security monitoring. Its HTS Qira services include intelligible design, incisive analysis and accessible platform. Its Medical Mime provides patient lifecycle management for Behavioral Health/Substance Abuse (BH/SA) treatment centers through its robust, efficient electronic medical records (EMR) purpose-built software. Its ClinLab is a Windows-based, Internet and web-enabled laboratory information management system. Its MEDtuning services deliver personalized medicine to modern clinical practices.